Year |
Citation |
Score |
2012 |
Yoder AR, Robinson JW, Dickey DM, Andersland J, Rose BA, Stone MD, Griffin TJ, Potter LR. A functional screen provides evidence for a conserved, regulatory, juxtamembrane phosphorylation site in guanylyl cyclase a and B. Plos One. 7: e36747. PMID 22590601 DOI: 10.1371/Journal.Pone.0036747 |
0.67 |
|
2010 |
Yoder AR, Stone MD, Griffin TJ, Potter LR. Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B. Biochemistry. 49: 10137-45. PMID 20977274 DOI: 10.1021/Bi101700E |
0.625 |
|
2009 |
Dickey DM, Yoder AR, Potter LR. A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation. The Journal of Biological Chemistry. 284: 19196-202. PMID 19458086 DOI: 10.1074/Jbc.M109.010777 |
0.703 |
|
2009 |
Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handbook of Experimental Pharmacology. 341-66. PMID 19089336 DOI: 10.1007/978-3-540-68964-5_15 |
0.507 |
|
2009 |
Yoder AR, Barbieri KA, Robinson JW, Potter LR. Possible identification of novel natriuretic peptide receptor phosphorylation sites by alanine/glutamate mutagenesis Bmc Pharmacology. 9. DOI: 10.1186/1471-2210-9-S1-P76 |
0.743 |
|
2009 |
Yoder AR, Stone MD, Griffin T, Potter LR. Determination of new phosphorylation sites within natriuretic peptide receptors using mass spectrometric methods Bmc Pharmacology. 9. DOI: 10.1186/1471-2210-9-S1-P75 |
0.735 |
|
2009 |
Dickey DM, Yoder AR, Potter LR. ANP mutation causes reduced proteolysis Bmc Pharmacology. 9: P12. DOI: 10.1186/1471-2210-9-S1-P12 |
0.559 |
|
2008 |
Yoder AR, Kruse AC, Earhart CA, Ohlendorf DH, Potter LR. Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice. Peptides. 29: 1575-81. PMID 18554750 DOI: 10.1016/J.Peptides.2008.04.020 |
0.714 |
|
Low-probability matches (unlikely to be authored by this person) |
2006 |
Carmella SG, Yoder A, Hecht SS. Combined analysis of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' plasma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1490-4. PMID 16896038 DOI: 10.1158/1055-9965.Epi-06-0199 |
0.236 |
|
2006 |
Lavergne SN, Kurian JR, Bajad SU, Maki JE, Yoder AR, Guzinski MV, Graziano FM, Trepanier LA. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso. Toxicology. 222: 25-36. PMID 16473451 DOI: 10.1016/J.Tox.2006.01.018 |
0.226 |
|
2013 |
Carmella SG, Ming X, Olvera N, Brookmeyer C, Yoder A, Hecht SS. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers. Chemical Research in Toxicology. 26: 1209-17. PMID 23837805 DOI: 10.1021/Tx400121N |
0.224 |
|
2005 |
Hecht SS, Chen M, Yoder A, Jensen J, Hatsukami D, Le C, Carmella SG. Longitudinal study of urinary phenanthrene metabolite ratios: effect of smoking on the diol epoxide pathway. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2969-74. PMID 16365018 DOI: 10.1158/1055-9965.Epi-05-0396 |
0.223 |
|
2010 |
Church TR, Anderson KE, Le C, Zhang Y, Kampa DM, Benoit AR, Yoder AR, Carmella SG, Hecht SS. Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 15: 345-52. PMID 20374068 DOI: 10.3109/13547501003753881 |
0.203 |
|
2005 |
Lavergne SN, Volkman EM, Maki JE, Yoder AR, Trepanier LA. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study. Toxicology. 208: 63-72. PMID 15664433 DOI: 10.1016/J.Tox.2004.11.009 |
0.203 |
|
2006 |
Hecht SS, Carmella SG, Yoder A, Chen M, Li ZZ, Le C, Dayton R, Jensen J, Hatsukami DK. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1805-11. PMID 17035385 DOI: 10.1158/1055-9965.Epi-06-0173 |
0.2 |
|
2004 |
Trepanier LA, Yoder AR, Bajad S, Beckwith MD, Bellehumeur JL, Graziano FM. Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 36: 1041-50. PMID 15247557 DOI: 10.1097/00126334-200408150-00007 |
0.2 |
|
2011 |
Thomas JL, Guo H, Carmella SG, Balbo S, Han S, Davis A, Yoder A, Murphy SE, An LC, Ahluwalia JS, Hecht SS. Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1213-21. PMID 21467230 DOI: 10.1158/1055-9965.Epi-10-1027 |
0.193 |
|
2019 |
Almehlisi A, Yoder A, Gabriel R, Schmidt U, Nguyen A. 204 Critical Care Medicine. 47: 84. DOI: 10.1097/01.ccm.0000550959.55256.a9 |
0.12 |
|
2024 |
Nguyen S, Carlson H, Yoder A, Bamlet WR, Oberg AL, Petersen GM, Carmella SG, Hecht SS, Jansen RJ. Polycyclic Aromatic Hydrocarbons and Pancreatic Cancer: An Analysis of the Blood Biomarker, -1,-2,3,-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and Selected Metabolism Gene SNPs. Nutrients. 16. PMID 38474816 DOI: 10.3390/nu16050688 |
0.12 |
|
2002 |
Hoffman SB, Yoder AR, Trepanier LA. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. Journal of Veterinary Pharmacology and Therapeutics. 25: 189-93. PMID 12081614 DOI: 10.1046/J.1365-2885.2002.00405.X |
0.051 |
|
Hide low-probability matches. |